Upregulation of calpain activity and expression in experimental allergic encephalomyelitis: A putative role for calpain in demyelination

Brain Research

Volumn 794, Issue 1, 1998, Pages 68-74

  Shields, Donald C ^a   Banik, Naren L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Calcium; Calpain; Calpastatin; Experimental allergic encephalomyelitis; Multiple sclerosis; Neutral proteinase

Indexed keywords

CALPAIN; CALPASTATIN; NEUTRAL PROTEINASE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMYELINATION; ENZYME ACTIVITY; MALE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD; TRANSCRIPTION REGULATION;

ANIMALS; CALCIUM-BINDING PROTEINS; CALPAIN; CYSTEINE PROTEINASE INHIBITORS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; MOLECULAR WEIGHT; MYELIN SHEATH; NEUROFILAMENT PROTEINS; POLYMERASE CHAIN REACTION; PROTEIN BIOSYNTHESIS; RATS; RATS, INBRED LEW; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 0032565668     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00193-0     Document Type: Article

References (57)

1. M. Azuma, E. Inoue, T. Oka, T.R. Shearer, Proteolysis by calpain is an underlying mechanism for formation of sugar cataract in rat lens, Curr. Eye Res. 14 (1995) 27-34.
2. M. Banay-Schwartz, T. Deguzman, M. Palkovits, A. Lajtha, Calpain activity in adult and aged human brain regions, Neurochem. Res. 19 (1994) 563-567.
3. 2+-mediated degradation of central nervous system (CNS) proteins: topographic and species variation, Metab. Brain Dis. 2 (1987) 117-125.
4. N.L. Banik, A.K. Chakrabarti, E.L. Hogan, Purification of an endogenous 68 kDa inhibitor of calcium-activated neutral proteinase (CANP) from bovine brain: immunoblot identification and characterization, J. Neurosci. Res. 25 (1990) 119-124.
5. N.L. Banik, A.K. Chakrabarti, E.L. Hogan, Role of calcium-activated neutral proteinase in myelin: its role and function, in: R. Martenson (Ed.), Myelin, Biology and Chemistry, Telford Press, Caldwell, NJ, 1992, pp. 571-597.
6. N.L. Banik, C.H. Chou, G.E. Deibler, H.C. Krutzch, E.L. Hogan, Peptide bond specificity of calpain: proteolysis of human myelin basic protein, J. Neurosci. Res. 37 (1994) 489-496.
7. N.L. Banik, D.C. Matzelle, G.G. Wilford, A. Osborne, E.L. Hogan, Increased calpain content and progressive degradation of neurofilament protein in spinal cord injury, Brain Res. 752 (1997) 301-306.
8. N.L. Banik, D. Lobo, E. Terry, E.L. Hogan, A new mechanism of methylprednisolone and other corticosteroids action demonstrated in vitro: inhibition of a proteinase (calpain) prevents myelin and cytoskeletal protein degradation, Brain Res. 748 (1997) 205-210.
9. R. Bartus, N.J. Heyward, P.J. Elliott, S.D. Sawyer, R.L. Dean, A. Akiyuama, J.A. Straub, S.L. Harbeson, Z. Li, Calpain inhibitor AK295 protects neurons from focal brain ischemia; effects of post-occlusion intra-arterial administration, Stroke 25 (1995) 2265-2270.
10. A.K. Chakrabarti, Y. Yoshida, J.M. Powers, I. Singh, E.L. Hogan, N.L. Banik, Calcium-activated neutral proteinases in rat brain and subcellular fractions, J. Neurosci. Res. 20 (1988) 351-358.
11. D.E. Clapham, Calcium signaling, Cell 80 (1995) 259-268.
12. 2+ stores of T lymphocytes: changes induced by in vitro and in vivo activation, Eur. J. Immunol. 24 (1994) 1365-1371.
13. 2+ activated protease possibly involved in myofibrillar turnover, Biochemistry 15 (1976) 2159-2167.
14. R.V. Deshpande, J.M. Goust, E.L. Hogan, N.L. Banik, Calpain secreted by activated human lymphoid cells degrades myelin, J. Neurosci. Res. 42 (1995) 259-265.
15. E.R. Einstein, J. Csejtey, K.B. Dalal, C.W.M. Adams, O. Bayliss, J. Hallpike, Proteolytic activity and basic protein loss in and around multiple sclerosis plaques: combined biochemical and histochemical observations, J. Neurochem. 19 (1972) 653-662.
16. G.A. Hashim, E.D. Day, L. Fredane, P. Intintola, E. Carvalho, Biological activity of region 65-102 of the myelin basic protein, J. Neurosci. Res. 16 (1986) 467-478.
17. A. Hata, S. Ohno, Y. Akita, K. Suzuki, Tandemly reiterated negative enhancer-like elements regulate transcription of a human gene for the large subunit of calcium-dependent protease, J. Biol. Chem. 264 (1989) 6404-6411.
18. E.L. Hogan, N.L. Banik, J.M. Goust, D. Lobo, Enzymes in cerebrospinal fluid: evidence for a calcium-activated neutral proteinase in CSF, in: A. Lowenthal, J. Raus (Eds.), Cellular and Humoral Components of Cerebrospinal Fluid in Multiple Sclerosis, Vol. 129, Elsevier, Amsterdam, 1987, pp. 479-488.
19. T. James, D. Matzelle, R. Bartus, E.L. Hogan, N.L. Banik, New inhibitors of calpain prevent degradation of cytoskeletal and myelin proteins in spinal cord in vitro, J. Neurosci. Res. 51 (1998) 218-222.
20. A. Kampfl, R.M. Posmantur, X. Zhao, E. Schmutzhard, G.L. Clifton, R.L. Hayes, Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: a review and update, J. Neurotrauma 14 (1997) 121-134.
21. U.K. Laemmle, Cleavage of structural proteins during the assembly of the head of Bacteriophage T, Nature 227 (1970) 680-685.
22. W.J. Lee, H. Ma, E. Takano, H.Q. Yang, M. Hatanaka, M. Maki, Molecular diversity in amino-terminal domains of human calpastatin by exon skipping, J. Biol. Chem. 267 (1992) 8437-8442.
23. C. Linnington, H. Lassmann, Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG), J. Neuroimmunol. 17 (1987) 61-69.
24. O.H. Lowry, N.J. Rosebrough, A.L. Farr, R.J. Randall, Protein measurement with the folin phenol reagent, J. Biol. Chem. 193 (1951) 265-275.
25. R. Martin, H.F. McFarland, Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis, Crit. Rev. Clin. Lab. Sci. 32 (1995) 121-182.
26. J.E.G. McCarthy, H. Kollmus, Cytoplasmic mRNA-protein interactions in eukaryotic gene expression, Trends Biochem. Sci. 20 (1995) 191-197.
27. R.L. Mellgren, Calcium-dependent proteases: an enzyme system active at cellular membranes, FASEB J. 1 (1987) 110-115.
28. J.R. Moller, Rapid conversion of myelin-associated glycoprotein to a soluble derivative in primates, Brain Res. 741 (1996) 27-31.
29. 2+-activated neutral proteinase specific for the intermediate filament proteins, vimentin and desmin, J. Biol. Chem. 257 (1982) 5544-5553.
30. J. Newcombe, P. Glynn, M.L. Cuzner, The immunological identification of brain proteins on cellulose nitrate in human demyelinating disease, J. Neurochem. 38 (1982) 267-274.
31. R.A. Nixon, Fodrin degradation by calcium-activated neutral proteinase (CANP) in retinal ganglion cell neurons and optic glia: preferential localization of CANP activated in neurons, J. Neurosci. 6 (1986) 1264-1271.
32. K. Ozawa, T. Saida, K. Saida, H. Nishitani, M. Kameyama, In vivo CNS demyelination mediated by anti-galactocerebroside antibody, Acta Neuropathol. (Berlin) 77 (1989) 621-628.
33. R. Posmantur, R.L. Hayes, C.E. Dixon, W.C. Taft, Neurofilament 68 and neurofilament 200 protein levels after traumatic brain injury, J. Neurotrauma 11 (1994) 533-545.
34. N.A. Rao, Chronic experimental allergic encephalomyelitis, Invest. Opthal. Vis. Sci. 20 (1981) 159-172.
35. K.E. Saatman, H. Murai, R.T. Bartus, D.H. Smith, N.J. Hayward, B.R. Perri, T.K. McIntosh, Calpain inhibitor Ak295 attenuates motor and cognitive deficits following experimental brain injury in the rat, Proc. Natl. Acad. Sci. USA 93 (1996) 3428-3433.
36. K. Sakai, H. Akanuma, K. Imahori, S. Kawashima, A unique specificity of a calcium activated neutral protease indicated in histone hydrolysis, J. Biochem. 101 (1987) 911-918.
37. S. Sato, R.H. Quarles, R.O. Brady, W.W. Tourtellotte, Elevated neutral proteinase activity in myelin from multiple sclerosis brain, Ann. Neurol. 15 (1984) 264-267.
38. W.W. Schlaepfer, Vesicular disruption of myelin simulated by exposure of nerve to calcium ionophore, Nature 265 (1977) 734-736.
39. W.W. Schlaepfer, U.J.P. Zimmerman, The degradation of neurofilaments by calpains, in: R.L. Mellgren, T. Murachi (Eds.), Intracellular Calcium-Dependent Proteolysis, CRC Press, Boca Raton, FL, 1990, pp. 241-250.
40. N.J. Scolding, J. Jones, D.A. Compston, B.P. Morgan, Oligodendrocyte susceptibility to injury by T-cell perform, Immunology 70 (1990) 6-10.
41. K.W. Selmaj, C.S. Raine, Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors, Neurology 45 (1995) S44-S49.
42. T.R. Shearer, L.L. David, Calpains in lens and cataract, in: R.L. Mellgren, T. Murachi (Eds.), Intracellular Calcium-Dependent Proteolysis, CRC Press, Boca Raton, FL, 1990, pp. 265-276.
43. D.C. Shields, G.E. Deibler, N.L. Banik, Increased calpain expression in EAE, J. Neurochem. 69 (1997) S226, (Abstr.).
44. D.C. Shields, W.R. Tyor, G.E. Deibler, N.L. Banik, Increased calpain expression in experimental demyelinating optic neuritis: an immunocytochemical study, Brain Res. 784 (1998) 299-304.
45. D.H. Silberberg, M.C. Manning, A.D. Schreiber, Tissue culture demyelination by normal human serum, Ann. Neurol. 15 (1984) 575-580.
46. R. Siman, C. Gall, L.S. Perlmutter, C. Christian, M. Baudry, G. Lynch, Distribution of calpain I, an enzyme associated with degenerative activity, in rat brain, Brain Res. 347 (1985) 399-403.
47. M.E. Smith, Neutral protease activity in lymphocytes of Lewis rats with acute experimental allergic encephalomyelitis, Neurochem. Res. 4 (1979) 689-702.
48. J.E. Springer, R.D. Azbill, S.E. Kennedy, J. George, J.W. Geddes, Rapid calpain I activation and cytoskeletal protein degradation following traumatic spinal cord injury: attenuation with riluzole pretreatment, J. Neurochem. 69 (1997) 1592-1600.
49. N. Standart, R.J. Jackson, Regulation of translation by specific protein/mRNA interactions, Biochimie 76 (1994) 867-879.
50. K. Suzuki, S. Imajoh, Y. Emori, H. Kawasaki, Y. Minami, S. Ohno, Calcium-activated neutral protease and its endogenous inhibitor, FEBS Lett. 220 (1987) 271-277.
51. K. Suzuki, H. Sorimachi, T. Yoshizawa, K. Kinbara, S. Ishiura, Calpain: novel family members, activation, and physiological function, Biol. Chem. 376 (1995) 523-529.
52. K. Takahashi, Calpain substrate specificity, in: R.L. Mellgren, T. Murachi (Eds.), Intracellular Calcium-Dependent Proteolysis, CRC Press, Boca Raton, FL, 1990, pp. 55-74.
53. H. Towbin, T. Stachlin, J. Gordon, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications, Proc. Natl. Acad. Sci. USA 76 (1979) 4350-4354.
54. T. Tsubata, K. Takahashi, Limited proteolysis of bovine myelin basic protein by calcium-dependent proteinase form bovine spinal cord, J. Biochem. 105 (1989) 23-28.
55. 2+-requiring neutral proteases in rat retina, Exp. Eye Res. 41 (1985) 97-103.
56. T. Yano, A. Kobayashi, S. Kurata, S. Natori, Purification and characterization of cathepsin B mRNA 3′-untranslated-region-binding protein (CBBP), a protein that represses cathepsin B mRNA translation, Eur. J. Biochem. 245 (1997) 260-265.
57. J.P. Zajicek, M. Wing, N.J. Scolding, D.A. Compston, Interactions between oligodendrocytes and microglia. A major role for complement and tumour necrosis factor in oligodendrocyte adherence and killing, Brain 115 (1992) 1611-1631.